Importantly, in the present study, mice receiving the treatment of a specific TAK1 inhibitor significantly ameliorated insulin resistance, glucose intolerance, inflammatory response and hepatic fatty acid accumulation triggered by HFD in NTG and in TRAF3-LTG mice. This evidence concerns the gene TRAF3 and Insulin resistance.